Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer
GlobeNewswire, Inc.
www.arlettapharmasolutions.com Global women’s health executive to lead Arletta in its development strategy focused on advancing Lybrido™’s (sildenafil/testosterone) Phase 2 MONARCH study following positive FDA correspondence Effective September 1,...
FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.
GlobeNewswire, Inc.
FDA approval expands Joenja indication to include children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) ages 4 to 11 who weigh at least 27kg Newly approved Joenja doses are expected to be available in October Leiden, the...
Long Island Healthcare Entrepreneur to Open New York’s First fit20 Studio in Miller Place
EIN Presswire
Founder of 23-location physical therapy practice adds international strength-training franchise to portfolio, with first New York studio planned for fall 2026 MILLER PLACE, NY, UNITED STATES, September 1, 2026 /EINPresswire.com/ -- fit20 USA...
Cryocooler Market to Reach USD 8.61 Billion by 2035, Driven by Aerospace, Defense, and Advanced Medical Applications
EIN Presswire
Healthcare retained roughly 29% of installations in 2025 as cryogen-free MRI deployments rose across emerging economies.
Is Dutch Elm Disease Still in Nebraska?
Nebraska Forest Service
The American elm tree, Ulmus americana, is a beautiful shade tree native to Nebraska.
MyHives Begins Engineering Validation of BEEKON+ Safety Device, First Shipments Planned for Early 2027
EIN Presswire
THE HAGUE, NETHERLANDS, September 11, 2026 /EINPresswire.com/ -- MyHives has begun engineering validation of BEEKON+, a credit-card-sized safety device that operates independently of a smartphone, with first shipments planned for early 2027. The...
NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
GlobeNewswire, Inc.
NAARDEN, The Netherlands and MIAMI, Aug. 26, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for...
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
GlobeNewswire, Inc.
WALTHAM, Mass., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the Wells Fargo 21st Annual Healthcare...
Food as Medicine Market to Reach USD 400.81 Billion by 2031, Growing at a CAGR of 9.5% — MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL , Aug. 24, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ estimates the global food as medicine Industry to grow from USD 254.15 billion in 2026 to USD 400.81 billion by 2031, registering a CAGR of 9.5% during the forecast period....
Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share
GlobeNewswire, Inc.
WARMINSTER, Pa., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced the commencement of a modified...
Silberstein & Miklos, P.C. (ASK4SAM) Expands Focus on Medical Malpractice Misdiagnosis and Delayed Diagnosis Claims in Manhattan
GlobeNewswire, Inc.
New York, NEW YORK, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Silberstein & Miklos, P.C. (ASK4SAM), a New York personal injury law firm representing victims of medical negligence, today announced an expanded focus on medical malpractice misdiagnosis and...
Influential Women Profiles Tania Van Den Houten: Wellness Educator, Author, Speaker, And Life Transformation Advocate
EIN Presswire
PENDLETON, OR, UNITED STATES, August 24, 2026 /EINPresswire.com/ -- Bringing More Than 30 Years of Wellness Experience to Life Coaching, Yoga Therapy, Health Education, and Integrative Lifestyle Change Pendleton, Oregon — Tania van den Houten is...
Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
GlobeNewswire, Inc.
WARMINSTER, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced plans to commence a modified...
Avania Appoints Francis Duhay, MD, as First Chief Medical Officer, Strengthening Therapeutic Leadership
EIN Presswire
Surgeon, inventor, and former Edwards Lifesciences CMO will expand Avania's internal therapeutic expertise as the company scales BILTHOVEN, NETHERLANDS, August 20, 2026 /EINPresswire.com/ -- Avania, a global MedTech-focused CRO purpose-built to...
ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026
GlobeNewswire, Inc.
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary...
Kynexis Extends Series A to €97 Million to Advance Potential First-in-Class Investigational Medicine for Cognitive Disorders
GlobeNewswire, Inc.
Novartis Venture Fund joins Kynexis’ existing investor syndicate, supporting the Company’s vision of becoming a leading late-stage cognition company Financing supports Phase 2 close-out activities and preparation for registrational studies of...
CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor
GlobeNewswire, Inc.
PRESS RELEASE CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor LONDON – 18 August 2026 -- CHARM Therapeutics (“CHARM”, “The Company”), a biotechnology company...
Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program
GlobeNewswire, Inc.
-- Announced following World Duchenne Awareness Day on September 7, grants are designed to support projects bridging healthcare disparities across the global Duchenne community -- BOSTON, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics,...
Pharmaceutical Contract Packaging Market to Reach $31.88 Bn by 2031, Big Pharma Holds 28%+ Demand - Mordor Intelligence
EIN Presswire
The pharmaceutical contract packaging market is projected to grow at a CAGR of 8.89% from 2026 to 2031, with North America holding the largest market share.
Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes
GlobeNewswire, Inc.
TEL AVIV, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully priced its offering of approximately $4.9 billion (equivalent) of senior notes (the...
Sign up for:
Healthcare News Netherlands
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.